The ADVANCE Trial: Clarifying the Role of Perindopril/Indapamide Fixed-Dose Combination in the Reduction of Cardiovascular and Renal Events in Patients with Diabetes Mellitus

Author： Waeber Bernard  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.5, 2009-10, pp. : 283-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BP lowering with perindopril/indapamide an ADVANCE in diabetes

By  

Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus

By Chwieduk Claudine M.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 349-361

Adis International

Access to resources Recommend Favorite

What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?

By Waeber Bernard  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2291-2299

Informa Healthcare

Access to resources Recommend Favorite

Perindopril 2mg/Indapamide 0.625mg: Fixed Low-Dose Combination

By McClellan K.J.   Markham A.  

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 297-302

Adis International

Access to resources Recommend Favorite

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

By Ono Yuri   Kameda Hiraku   Cho Kyu Yong  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite